MSC P/NC MP E X A MI NATI ON PRE PA RATI ON SE RI E S
NAMS Menopause
Certification Exam
100 questions and answers with detailed evidence-
based rationales, aligned with the Menopause Society
(NAMS) examination blueprint for the 2026/2027 cycle.
Verified Question Bank | Graded A+
2 0 2 0 2 7 E D I TI O N · C O M P L E TE H I G H -Y I E L D TE S T B A N K
,NAMS Menopause Certification Exam | 100 Questions and Answers (Graded A+) 2026/2027 Edition
NAMS MENOPAUSE CERTIFICATION EXAM
100 Questions and Answers (Graded A+) | 2026/2027 Edition
Total Questions: 100 | Format: Multiple choice, four options (A-D), one correct answer with the verified
answer printed beneath each item | Cognitive Mix: 25% recall, 50% application, 25% analysis
Alignment: Content reflects the Menopause Society (formerly NAMS) MSCP/NCMP examination blueprint
and competency domains, current Menopause Society position papers, and recent clinical trial evidence,
including the 2022 Hormone Therapy Position Statement, the 2023 Nonhormone Therapy Position Statement,
WHI and SWAN findings, neurokinin receptor antagonist trials, and 2026/2027 updates in menopause
pharmacotherapy.
Directions: Select the single best answer for each question. The verified answer is marked directly beneath
the options, followed by an evidence-based rationale explaining the correct choice and the flaws in the
distractors. Study each rationale carefully: it reflects the physiology, staging criteria, therapy selection, risk
communication, and patient-centered counseling expected of a certified menopause practitioner.
Contents
Section 1: Reproductive Physiology and Menopause Staging 2
Section 2: Symptom Management 9
Section 3: Health Disorders and Clinical Assessment 16
Section 4: Treatment: Hormonal and Non-Hormonal Therapies 23
Section 5: Preventive Care, Counseling, and Special Populations 31
Section 6: Comprehensive Cases and Clinical Application 38
1
,NAMS Menopause Certification Exam | 100 Questions and Answers (Graded A+) 2026/2027 Edition
Section 1: Reproductive Physiology and Menopause Staging
Reproductive Aging, STRAW+10 Staging, Hormonal Changes, Ovarian Aging, and POI | Questions 1-18
Q1: Which statement MOST accurately defines natural menopause as recognized by the
Menopause Society (formerly NAMS)?
A. A clinical syndrome diagnosed by a single serum FSH measurement above 40 mIU/mL
at any point in the menstrual cycle
B. The permanent cessation of menses recognized retrospectively after 12 consecutive
months of amenorrhea without another pathological or physiological cause [CORRECT]
C. The point at which serum estradiol falls below 50 pg/mL on two consecutive laboratory
assessments
D. The final ovulatory cycle, confirmed by a mid-luteal serum progesterone level below 3
ng/mL
Correct Answer: B
Rationale: Natural menopause is a retrospective clinical diagnosis made after 12 consecutive months
of amenorrhea in the absence of other causes, with no confirmatory laboratory test required. Option A
is incorrect because a single FSH value is unreliable during the menopause transition because of
marked intercycle and intracycle variability. Option C describes an arbitrary estradiol threshold that has
no diagnostic standing, and Option D describes luteal insufficiency rather than menopause.
Q2: What is the average age of natural menopause in the United States, according to SWAN
study data?
A. 51 years [CORRECT]
B. 45 years
C. 56 years
D. 41 years
Correct Answer: A
Rationale: The average age at natural menopause in the United States is approximately 51 years, with a
normal range of roughly 45 to 55 years. Age 45 marks the lower boundary that separates early
menopause from normal timing, not the average. Age 56 would fall into late menopause, and age 41
would represent premature loss of ovarian function rather than natural menopause.
Q3: A healthy 47-year-old woman reports that her previously regular 28-day cycles have become
persistently variable, ranging from 21 to 32 days, with a difference of 8 days or more between
her shortest and longest cycles. Using the STRAW+10 staging system, she should be classified in
which stage?
A. Late reproductive stage
B. Early postmenopause transition
C. Early menopause transition [CORRECT]
D. Late menopause transition
2
, NAMS Menopause Certification Exam | 100 Questions and Answers (Graded A+) 2026/2027 Edition
Correct Answer: C
Rationale: A persistent difference of 7 days or more in cycle length between consecutive cycles
defines the early menopause transition (STRAW stage -2). The late transition (stage -1) requires
intervals of amenorrhea of 60 days or more, which this patient has not experienced. The late
reproductive stage (stage -3) is characterized by subtle cycle changes of less than 7 days, and early
postmenopause is not applicable because menses persist.
Q4: A 51-year-old woman presents after skipping menses entirely for 10 weeks on two separate
occasions over the past 6 months. According to STRAW+10 criteria, this bleeding pattern places
her in which stage of reproductive aging?
A. Late menopause transition [CORRECT]
B. Early menopause transition
C. Late reproductive stage
D. Postmenopause, stage +1a
Correct Answer: A
Rationale: Intervals of amenorrhea lasting at least 60 days define the late menopause transition
(STRAW stage -1), exactly as described in this scenario. A 60-day gap is far beyond the 7-day
variability threshold that defines the early transition. Postmenopause cannot be staged because the
12-month amenorrhea requirement has not been met, and the late reproductive stage involves subtle
cycle changes without skipped intervals.
Q5: In the STRAW+10 staging system, a woman whose final menstrual period occurred 3.5
years ago would be assigned to which postmenopausal subdivision?
A. Stage +1a
B. Stage +1b [CORRECT]
C. Stage +1c
D. Stage +2
Correct Answer: B
Rationale: Stage +1b spans approximately years 1 through 5 or 6 after the final menstrual period, so a
woman 3.5 years past menopause falls in +1b. Stage +1a covers the first 12 months after the final
menstrual period, when AMH becomes undetectable and antral follicle counts are very low. Stage +1c
comprises all remaining years of postmenopause until death, and no stage +2 exists in the STRAW+10
system.
Q6: Which laboratory marker BEST reflects the size of the remaining ovarian follicle pool
across the reproductive lifespan and becomes undetectable roughly 5 years before the final
menstrual period?
A. Inhibin B
B. Sex hormone-binding globulin (SHBG)
C. Luteinizing hormone (LH)
D. Anti-Mullerian hormone (AMH) [CORRECT]
3
NAMS Menopause
Certification Exam
100 questions and answers with detailed evidence-
based rationales, aligned with the Menopause Society
(NAMS) examination blueprint for the 2026/2027 cycle.
Verified Question Bank | Graded A+
2 0 2 0 2 7 E D I TI O N · C O M P L E TE H I G H -Y I E L D TE S T B A N K
,NAMS Menopause Certification Exam | 100 Questions and Answers (Graded A+) 2026/2027 Edition
NAMS MENOPAUSE CERTIFICATION EXAM
100 Questions and Answers (Graded A+) | 2026/2027 Edition
Total Questions: 100 | Format: Multiple choice, four options (A-D), one correct answer with the verified
answer printed beneath each item | Cognitive Mix: 25% recall, 50% application, 25% analysis
Alignment: Content reflects the Menopause Society (formerly NAMS) MSCP/NCMP examination blueprint
and competency domains, current Menopause Society position papers, and recent clinical trial evidence,
including the 2022 Hormone Therapy Position Statement, the 2023 Nonhormone Therapy Position Statement,
WHI and SWAN findings, neurokinin receptor antagonist trials, and 2026/2027 updates in menopause
pharmacotherapy.
Directions: Select the single best answer for each question. The verified answer is marked directly beneath
the options, followed by an evidence-based rationale explaining the correct choice and the flaws in the
distractors. Study each rationale carefully: it reflects the physiology, staging criteria, therapy selection, risk
communication, and patient-centered counseling expected of a certified menopause practitioner.
Contents
Section 1: Reproductive Physiology and Menopause Staging 2
Section 2: Symptom Management 9
Section 3: Health Disorders and Clinical Assessment 16
Section 4: Treatment: Hormonal and Non-Hormonal Therapies 23
Section 5: Preventive Care, Counseling, and Special Populations 31
Section 6: Comprehensive Cases and Clinical Application 38
1
,NAMS Menopause Certification Exam | 100 Questions and Answers (Graded A+) 2026/2027 Edition
Section 1: Reproductive Physiology and Menopause Staging
Reproductive Aging, STRAW+10 Staging, Hormonal Changes, Ovarian Aging, and POI | Questions 1-18
Q1: Which statement MOST accurately defines natural menopause as recognized by the
Menopause Society (formerly NAMS)?
A. A clinical syndrome diagnosed by a single serum FSH measurement above 40 mIU/mL
at any point in the menstrual cycle
B. The permanent cessation of menses recognized retrospectively after 12 consecutive
months of amenorrhea without another pathological or physiological cause [CORRECT]
C. The point at which serum estradiol falls below 50 pg/mL on two consecutive laboratory
assessments
D. The final ovulatory cycle, confirmed by a mid-luteal serum progesterone level below 3
ng/mL
Correct Answer: B
Rationale: Natural menopause is a retrospective clinical diagnosis made after 12 consecutive months
of amenorrhea in the absence of other causes, with no confirmatory laboratory test required. Option A
is incorrect because a single FSH value is unreliable during the menopause transition because of
marked intercycle and intracycle variability. Option C describes an arbitrary estradiol threshold that has
no diagnostic standing, and Option D describes luteal insufficiency rather than menopause.
Q2: What is the average age of natural menopause in the United States, according to SWAN
study data?
A. 51 years [CORRECT]
B. 45 years
C. 56 years
D. 41 years
Correct Answer: A
Rationale: The average age at natural menopause in the United States is approximately 51 years, with a
normal range of roughly 45 to 55 years. Age 45 marks the lower boundary that separates early
menopause from normal timing, not the average. Age 56 would fall into late menopause, and age 41
would represent premature loss of ovarian function rather than natural menopause.
Q3: A healthy 47-year-old woman reports that her previously regular 28-day cycles have become
persistently variable, ranging from 21 to 32 days, with a difference of 8 days or more between
her shortest and longest cycles. Using the STRAW+10 staging system, she should be classified in
which stage?
A. Late reproductive stage
B. Early postmenopause transition
C. Early menopause transition [CORRECT]
D. Late menopause transition
2
, NAMS Menopause Certification Exam | 100 Questions and Answers (Graded A+) 2026/2027 Edition
Correct Answer: C
Rationale: A persistent difference of 7 days or more in cycle length between consecutive cycles
defines the early menopause transition (STRAW stage -2). The late transition (stage -1) requires
intervals of amenorrhea of 60 days or more, which this patient has not experienced. The late
reproductive stage (stage -3) is characterized by subtle cycle changes of less than 7 days, and early
postmenopause is not applicable because menses persist.
Q4: A 51-year-old woman presents after skipping menses entirely for 10 weeks on two separate
occasions over the past 6 months. According to STRAW+10 criteria, this bleeding pattern places
her in which stage of reproductive aging?
A. Late menopause transition [CORRECT]
B. Early menopause transition
C. Late reproductive stage
D. Postmenopause, stage +1a
Correct Answer: A
Rationale: Intervals of amenorrhea lasting at least 60 days define the late menopause transition
(STRAW stage -1), exactly as described in this scenario. A 60-day gap is far beyond the 7-day
variability threshold that defines the early transition. Postmenopause cannot be staged because the
12-month amenorrhea requirement has not been met, and the late reproductive stage involves subtle
cycle changes without skipped intervals.
Q5: In the STRAW+10 staging system, a woman whose final menstrual period occurred 3.5
years ago would be assigned to which postmenopausal subdivision?
A. Stage +1a
B. Stage +1b [CORRECT]
C. Stage +1c
D. Stage +2
Correct Answer: B
Rationale: Stage +1b spans approximately years 1 through 5 or 6 after the final menstrual period, so a
woman 3.5 years past menopause falls in +1b. Stage +1a covers the first 12 months after the final
menstrual period, when AMH becomes undetectable and antral follicle counts are very low. Stage +1c
comprises all remaining years of postmenopause until death, and no stage +2 exists in the STRAW+10
system.
Q6: Which laboratory marker BEST reflects the size of the remaining ovarian follicle pool
across the reproductive lifespan and becomes undetectable roughly 5 years before the final
menstrual period?
A. Inhibin B
B. Sex hormone-binding globulin (SHBG)
C. Luteinizing hormone (LH)
D. Anti-Mullerian hormone (AMH) [CORRECT]
3
